ZERENEX E/4047831

CAS16951-33-0

ZERENEX E/4047831 (CAS 16951-33-0, C8H7N3OS) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.

Chemical structure of ZERENEX E/4047831
C8H7N3OS · 193.23 g/mol
CAS No.
16951-33-0
Formula
C8H7N3OS
Mol. weight
193.23 g/mol

Chemical Specifications

Identifiers

CAS number 16951-33-0
Product name ZERENEX E/4047831
Chinese name 3-氨基-2-硫代-2,3-二氢喹唑啉-4(1H)-酮盐酸盐
Synonyms ZERENEX E/4047831; ART-CHEM-BB B020621; AKOS B020621; 3-AMINO-2-MERCAPTO-3H-QUINAZOLIN-4-ONE; 3-AMINO-2-MERCAPTOQUINAZOLIN-4-ONE; 3-amino-2-thioxo-2,3-dihydroquinazolin-4(1H)-one; 4(1H)-quinazolinone, 3-amino-2,3-dihydro-2-thioxo-
Molecular formula C8H7N3OS
Molecular weight 193.23 g/mol

Physical and chemical properties

Boiling Point 178.5 ( ℃ )

Packaging, Storage & Transport

Available pack sizes 5kg, 1kg, 500g, 100g, 50g, 10g

Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.

Frequently Asked Questions

What is the CAS number of ZERENEX E/4047831?

The CAS Registry Number of ZERENEX E/4047831 is 16951-33-0. ZERENEX E/4047831 is also known as ZERENEX E/4047831; ART-CHEM-BB B020621; AKOS B020621.

What is the molecular formula and molecular weight of ZERENEX E/4047831?

The molecular formula of ZERENEX E/4047831 is C8H7N3OS, and its molecular weight is 193.23 g/mol.

How can I request a quotation for ZERENEX E/4047831?

Send an inquiry for ZERENEX E/4047831 (CAS 16951-33-0) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.

Request a Quote for ZERENEX E/4047831

Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.

Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.